Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Naseem Zojwalla Insider Profile
4 Followers
Naseem Zojwalla, CMO at Olema Pharmaceuticals, holds 80.36K shares in Olema Pharmaceuticals (Ticker: OLMA). Most recently, Naseem Zojwalla Bought $13,700 shares of Olema Pharmaceuticals on Mar 20, 2024 for an estimated value of 66.72K.
Profitable Transactions
1 out of 5 Profitable Transactions
Average Return
-4.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Naseem Zojwalla's holdings
Insider Roles
CMO
Roles that Naseem Zojwalla holds in companies
Most Profitable Insider Trade
The most profitable trade made by Naseem Zojwalla
Naseem Zojwalla's Trading History
List of latest transactions for each holding click on a transaction to see Naseem Zojwalla's performance on stock
You May Also Like
Naseem Zojwalla insider profile FAQ
What is the percentage of profitable transactions made by Naseem Zojwalla?
The percentage of profitable transactions made by Naseem Zojwalla is 20%.
What is the average return per transaction made by Naseem Zojwalla?
The average return per transaction made by Naseem Zojwalla is -4.70%.
What stocks does Naseem Zojwalla hold?
Naseem Zojwalla holds: OLMA stocks.
What was Naseem Zojwalla’s latest transaction?
Naseem Zojwalla latest transaction was an Informative Buy of $66.72K.
What was Naseem Zojwalla's most profitable transaction?
Naseem Zojwalla’s most profitable transaction was an Informative Sell of OLMA stock on November 22, 2023. The return on the trade was 15.20%.
What is Naseem Zojwalla's role in Olema Pharmaceuticals?
Naseem Zojwalla's role in Olema Pharmaceuticals is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.